- Home
- NXN vs THTX Comparison
NXN vs THTX Comparison
Compare NXN & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXN
- THTX
- Stock Information
- Founded
- NXN 1992
- THTX 1993
- Country
- NXN United States
- THTX Canada
- Employees
- NXN N/A
- THTX N/A
- Industry
- NXN Trusts Except Educational Religious and Charitable
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- NXN Finance
- THTX Health Care
- Exchange
- NXN Nasdaq
- THTX Nasdaq
- Market Cap
- NXN 47.4M
- THTX 55.3M
- IPO Year
- NXN N/A
- THTX N/A
- Fundamental
- Price
- NXN $12.10
- THTX $1.28
- Analyst Decision
- NXN
- THTX Hold
- Analyst Count
- NXN 0
- THTX 1
- Target Price
- NXN N/A
- THTX N/A
- AVG Volume (30 Days)
- NXN 9.7K
- THTX 47.4K
- Earning Date
- NXN 01-01-0001
- THTX 10-10-2024
- Dividend Yield
- NXN 4.23%
- THTX N/A
- EPS Growth
- NXN N/A
- THTX N/A
- EPS
- NXN 0.24
- THTX N/A
- Revenue
- NXN N/A
- THTX $84,316,000.00
- Revenue This Year
- NXN N/A
- THTX $5.87
- Revenue Next Year
- NXN N/A
- THTX $15.10
- P/E Ratio
- NXN $48.42
- THTX N/A
- Revenue Growth
- NXN N/A
- THTX 5.75
- 52 Week Low
- NXN $10.64
- THTX $0.88
- 52 Week High
- NXN $12.45
- THTX $2.58
- Technical
- Relative Strength Index (RSI)
- NXN 53.35
- THTX 53.81
- Support Level
- NXN $12.03
- THTX $1.20
- Resistance Level
- NXN $12.16
- THTX $1.32
- Average True Range (ATR)
- NXN 0.11
- THTX 0.08
- MACD
- NXN -0.01
- THTX 0.01
- Stochastic Oscillator
- NXN 20.05
- THTX 60.00
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.